About
EarlySight is a Swiss startup based in Geneva, founded in 2019, that specializes in medical technology for ophthalmology. The company aims to reduce vision loss by enabling earlier detection and better monitoring of eye diseases, including age-related macular degeneration, glaucoma, central serous chorioretinopathy, and inherited retinal diseases. The flagship product, Cellularis Discovery, is a high-performance eye imaging instrument that offers a tenfold increase in resolution compared to standard devices. It allows for detailed visualization of the retina at the cellular level, capturing critical retinal layers with micrometer lateral resolution. This advanced imaging capability supports early diagnosis and precise monitoring of retinal diseases. Additionally, EarlySight is developing AI-driven digital biomarker software to analyze high-resolution images, helping eye care professionals detect subtle changes in retinal tissue. Targeting eye doctors and ophthalmologists, EarlySight positions itself at the forefront of imaging technology and artificial intelligence in ophthalmology, striving to enhance patient care through innovative solutions.
Technologies
Keywords
Company Information
-
Employees 9
-
Founded 2019
-
Total Funding $7027154
Location
15 Avenue de Secheron, Geneva, Geneva, Switzerland, 1202
